US Stock MarketDetailed Quotes

TuHURA Biosciences (HURA)

Watchlist
  • 0.6793
  • -0.0076-1.11%
Close Jan 22 16:00 ET
  • 0.7005
  • +0.0212+3.12%
Post 18:24 ET
41.25MMarket Cap-1.27P/E (TTM)

TuHURA Biosciences (HURA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-11.09M
-23.34%-6.25M
-23.58%-4.74M
-23.24%-14.73M
-5.07M
-18.60%-3.83M
-59.17%-11.95M
-74.58%-3.23M
-14.40%-7.51M
-1.85M
Net income from continuing operations
---7.1M
-80.88%-9.52M
-37.63%-6.66M
26.04%-21.68M
---5.27M
74.12%-4.84M
-212.96%-29.32M
-778.02%-18.71M
-33.51%-9.37M
---2.13M
Operating gains losses
----
----
----
--313.77K
--347.09K
---12.09K
----
----
27.36%-294.07K
----
Depreciation and amortization
--21.29K
-62.47%13.37K
-59.02%14.06K
-34.20%116.71K
--35.63K
-43.24%34.31K
-52.46%177.38K
-35.70%60.45K
-2.00%373.09K
--94.01K
Other non cash items
----
----
----
24,849.73%1.28M
--420.79K
--17.38K
--5.12K
----
----
----
Change In working capital
---5.95M
310.93%1.86M
-23.12%487.16K
574.97%3.29M
---879.57K
166.43%633.7K
-68.83%486.92K
-711.09%-953.95K
421.26%1.56M
--156.11K
-Change in payables and accrued expense
---6.21M
275.36%1.86M
-35.60%445.54K
979.19%3.64M
---1.06M
156.86%691.88K
-81.73%337.75K
-984.63%-1.22M
493.01%1.85M
--137.55K
-Change in other current assets
--262.46K
-100.88%-1.58K
171.52%41.61K
-340.20%-358.33K
--179.28K
-122.13%-58.19K
152.07%149.18K
1,316.83%262.88K
-3,455.35%-286.51K
--18.55K
Cash from discontinued investing activities
Operating cash flow
---11.09M
-23.34%-6.25M
-23.58%-4.74M
-23.24%-14.73M
---5.07M
-18.60%-3.83M
-59.17%-11.95M
-74.58%-3.23M
-14.40%-7.51M
---1.85M
Investing cash flow
Cash flow from continuing investing activities
0
-328.69%-156.46K
-1.15M
-366.69%-6.05M
-36.5K
0
-3,474.93%-1.3M
-1.2M
-1,006.01%-36.28K
0
Net PPE purchase and sale
--0
84.76%-5.56K
---42.67K
26.91%-57.91K
---36.5K
--0
-118.39%-79.22K
----
-1,006.01%-36.28K
----
Net business purchase and sale
--0
----
----
-392.30%-5.99M
----
--0
---1.22M
---1.2M
--0
--0
Net other investing changes
----
----
---1.11M
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
-328.69%-156.46K
---1.15M
-366.69%-6.05M
---36.5K
--0
-3,474.93%-1.3M
---1.2M
-1,006.01%-36.28K
--0
Financing cash flow
Cash flow from continuing financing activities
5.27M
-32.85%8.7M
-111.83%-547.88K
1,019.17%29.77M
12.95M
4.63M
-83.63%2.66M
0
130.69%16.25M
-150K
Net issuance payments of debt
---576.35K
--0
--0
963.99%28.57M
--14.17M
--4.9M
867.14%2.69M
--0
-219.02%-350K
---150K
Net common stock issuance
--6.2M
----
----
20,301.20%5M
----
----
---24.75K
----
--0
----
Net preferred stock issuance
----
----
----
----
----
----
----
----
1,342.98%16.6M
----
Cash dividends paid
---2.09K
---2.09K
---2.09K
----
--0
--0
----
----
----
----
Proceeds from stock option exercised by employees
--0
--3.12M
--504.21K
--2.05M
--0
--0
--0
----
----
----
Net other financing activities
---347.97K
72.68%-331.36K
-285.61%-1.05M
---5.84M
---1.21M
---272.3K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--5.27M
-32.85%8.7M
-111.83%-547.88K
1,019.17%29.77M
--12.95M
--4.63M
-83.63%2.66M
--0
130.69%16.25M
---150K
Net cash flow
Beginning cash position
--8.51M
39.41%6.22M
245.35%12.66M
-74.29%3.67M
--4.46M
-74.29%3.67M
156.98%14.25M
156.98%14.25M
9.43%5.55M
--5.55M
Current changes in cash
---5.82M
-70.79%2.29M
-908.25%-6.44M
184.93%8.99M
--7.85M
117.97%796.46K
-221.60%-10.59M
-121.45%-4.43M
1,721.77%8.71M
---2M
End cash Position
--2.7M
-30.85%8.51M
39.41%6.22M
245.35%12.66M
--12.31M
-54.57%4.46M
-74.29%3.67M
177.06%9.82M
156.98%14.25M
--3.54M
Free cash flow
---11.09M
-22.57%-6.25M
-24.69%-4.78M
-22.91%-14.79M
---5.1M
-18.60%-3.83M
-59.45%-12.03M
-74.58%-3.23M
-14.89%-7.54M
---1.85M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -11.09M-23.34%-6.25M-23.58%-4.74M-23.24%-14.73M-5.07M-18.60%-3.83M-59.17%-11.95M-74.58%-3.23M-14.40%-7.51M-1.85M
Net income from continuing operations ---7.1M-80.88%-9.52M-37.63%-6.66M26.04%-21.68M---5.27M74.12%-4.84M-212.96%-29.32M-778.02%-18.71M-33.51%-9.37M---2.13M
Operating gains losses --------------313.77K--347.09K---12.09K--------27.36%-294.07K----
Depreciation and amortization --21.29K-62.47%13.37K-59.02%14.06K-34.20%116.71K--35.63K-43.24%34.31K-52.46%177.38K-35.70%60.45K-2.00%373.09K--94.01K
Other non cash items ------------24,849.73%1.28M--420.79K--17.38K--5.12K------------
Change In working capital ---5.95M310.93%1.86M-23.12%487.16K574.97%3.29M---879.57K166.43%633.7K-68.83%486.92K-711.09%-953.95K421.26%1.56M--156.11K
-Change in payables and accrued expense ---6.21M275.36%1.86M-35.60%445.54K979.19%3.64M---1.06M156.86%691.88K-81.73%337.75K-984.63%-1.22M493.01%1.85M--137.55K
-Change in other current assets --262.46K-100.88%-1.58K171.52%41.61K-340.20%-358.33K--179.28K-122.13%-58.19K152.07%149.18K1,316.83%262.88K-3,455.35%-286.51K--18.55K
Cash from discontinued investing activities
Operating cash flow ---11.09M-23.34%-6.25M-23.58%-4.74M-23.24%-14.73M---5.07M-18.60%-3.83M-59.17%-11.95M-74.58%-3.23M-14.40%-7.51M---1.85M
Investing cash flow
Cash flow from continuing investing activities 0-328.69%-156.46K-1.15M-366.69%-6.05M-36.5K0-3,474.93%-1.3M-1.2M-1,006.01%-36.28K0
Net PPE purchase and sale --084.76%-5.56K---42.67K26.91%-57.91K---36.5K--0-118.39%-79.22K-----1,006.01%-36.28K----
Net business purchase and sale --0---------392.30%-5.99M------0---1.22M---1.2M--0--0
Net other investing changes -----------1.11M----------------------------
Cash from discontinued investing activities
Investing cash flow --0-328.69%-156.46K---1.15M-366.69%-6.05M---36.5K--0-3,474.93%-1.3M---1.2M-1,006.01%-36.28K--0
Financing cash flow
Cash flow from continuing financing activities 5.27M-32.85%8.7M-111.83%-547.88K1,019.17%29.77M12.95M4.63M-83.63%2.66M0130.69%16.25M-150K
Net issuance payments of debt ---576.35K--0--0963.99%28.57M--14.17M--4.9M867.14%2.69M--0-219.02%-350K---150K
Net common stock issuance --6.2M--------20,301.20%5M-----------24.75K------0----
Net preferred stock issuance --------------------------------1,342.98%16.6M----
Cash dividends paid ---2.09K---2.09K---2.09K------0--0----------------
Proceeds from stock option exercised by employees --0--3.12M--504.21K--2.05M--0--0--0------------
Net other financing activities ---347.97K72.68%-331.36K-285.61%-1.05M---5.84M---1.21M---272.3K----------------
Cash from discontinued financing activities
Financing cash flow --5.27M-32.85%8.7M-111.83%-547.88K1,019.17%29.77M--12.95M--4.63M-83.63%2.66M--0130.69%16.25M---150K
Net cash flow
Beginning cash position --8.51M39.41%6.22M245.35%12.66M-74.29%3.67M--4.46M-74.29%3.67M156.98%14.25M156.98%14.25M9.43%5.55M--5.55M
Current changes in cash ---5.82M-70.79%2.29M-908.25%-6.44M184.93%8.99M--7.85M117.97%796.46K-221.60%-10.59M-121.45%-4.43M1,721.77%8.71M---2M
End cash Position --2.7M-30.85%8.51M39.41%6.22M245.35%12.66M--12.31M-54.57%4.46M-74.29%3.67M177.06%9.82M156.98%14.25M--3.54M
Free cash flow ---11.09M-22.57%-6.25M-24.69%-4.78M-22.91%-14.79M---5.1M-18.60%-3.83M-59.45%-12.03M-74.58%-3.23M-14.89%-7.54M---1.85M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More